Search research articles
Contact Us
Filters
Showing results (121-130 of 265) with videos related to
Page
of 27
Sort By:
The Oncologist
|
April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Raphael Colle, Sara Lonardi, Marine Cachanado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology
Kanwal Pratap Singh Raghav, Sminil Mahajan, James C Yao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2014
Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer
V K Morris, F A San Lucas, M J Overman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
Impact of RAS/BRAF V600E mutations on the tumor immune microenvironment in mismatch repair deficient /microsatellite instability colorectal cancers
Mohamed E Salem, Alberto Puccini, Elizabeth Mauer, et al.
The Oncologist
|
October 24, 2013
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas
Kanwal P S Raghav, Aditya V Shetty, Syed M A Kazmi, et al.
Journal of the American College of Surgeons
|
March 15, 2022
Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases
Yujiro Nishioka, Yun Shin Chun, Michael J Overman, et al.
Frontiers in Oncology
|
October 10, 2022
Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
Preeti Kanikarla Marie, Alexey V Sorokin, Lea A Bitner, et al.
British Journal of Cancer
|
June 9, 2016
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
Michael S Lee, Elizabeth J McGuffey, Jeffrey S Morris, et al.
British Journal of Cancer
|
August 1, 2020
Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer
Kanwal Raghav, John P Shen, Alexandre A Jácome, et al.
Clinical Colorectal Cancer
|
September 13, 2018
Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics
Maliha Khan, Jonathan M Loree, Shailesh M Advani, et al.
Page
of 27
Search research articles
Search
Showing results (121-130 of 265) with videos related to
Sort By:
Page
of 27
The Oncologist
|
April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Raphael Colle, Sara Lonardi, Marine Cachanado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology
Kanwal Pratap Singh Raghav, Sminil Mahajan, James C Yao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2014
Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer
V K Morris, F A San Lucas, M J Overman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
Impact of RAS/BRAF V600E mutations on the tumor immune microenvironment in mismatch repair deficient /microsatellite instability colorectal cancers
Mohamed E Salem, Alberto Puccini, Elizabeth Mauer, et al.
The Oncologist
|
October 24, 2013
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas
Kanwal P S Raghav, Aditya V Shetty, Syed M A Kazmi, et al.
Journal of the American College of Surgeons
|
March 15, 2022
Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases
Yujiro Nishioka, Yun Shin Chun, Michael J Overman, et al.
Frontiers in Oncology
|
October 10, 2022
Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
Preeti Kanikarla Marie, Alexey V Sorokin, Lea A Bitner, et al.
British Journal of Cancer
|
June 9, 2016
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
Michael S Lee, Elizabeth J McGuffey, Jeffrey S Morris, et al.
British Journal of Cancer
|
August 1, 2020
Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer
Kanwal Raghav, John P Shen, Alexandre A Jácome, et al.
Clinical Colorectal Cancer
|
September 13, 2018
Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics
Maliha Khan, Jonathan M Loree, Shailesh M Advani, et al.
Page
of 27